Personal or first-degree family breast cancer history: which has higher impact on tumor detection and tumor size in breast cancer

被引:6
|
作者
Schwab, Fabienne Dominique [1 ]
Kilic, Nerbil [2 ]
Huang, Dorothy Jane [1 ]
Schmid, Seraina Margaretha [3 ]
Vetter, Marcus [4 ]
Schoetzau, Andreas [5 ]
Gueth, Uwe [1 ,6 ,7 ]
机构
[1] Univ Basel Hosp, Dept Gynecol & Obstet, CH-4031 Basel, Switzerland
[2] Cantonal Hosp St Gallen, Dept Oncol, CH-9007 St Gallen, Switzerland
[3] Spital Grabs, Dept Gynecol & Obstet, CH-9472 Grabs, Switzerland
[4] UHB, Dept Oncol, CH-4031 Basel, Switzerland
[5] Eudox Inst Biomath, CH-4052 Basel, Switzerland
[6] Cantonal Hosp Winterthur, Dept Gynecol & Obstet, CH-8401 Winterthur, Switzerland
[7] Breast Ctr SenoSuisse, CH-8401 Winterthur, Switzerland
关键词
Breast cancer; Family history; Personal history; Detection method; Mammography screening; Tumor size; FOLLOW-UP; LOCAL RECURRENCE; MAMMOGRAPHY; WOMEN; RISK; PROGNOSIS;
D O I
10.1007/s00404-014-3592-y
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A woman's risk of developing breast cancer (BC) is increased if she has a personal history (PH) or family history (FH) of the disease. We compared the impact of the two risk factors PH and FH on tumor detection and tumor size at diagnosis in a cohort of BC patients. The study cohort comprised 1,037 invasive BC patients (a parts per thousand currency sign70 years at diagnosis). From these, 92 patients (8.5 %) had a positive PH and 151 patients (13.7 %) had a positive first-degree FH. Compared to the tumors of patients without PH or FH, the lesions of patients who had a positive PH or a positive FH were more often found by radiologic breast examinations (RBE) (PH: 49.4 %, FH: 43.4 %, no PH/FH: 26.2 %; both comparisons p < 0.001). In patients with a positive FH, the tumors were slightly less often found by RBE as in patients with a positive PH (p = 0.468). Patients with a positive PH or FH had smaller tumors compared with those without such a history (PH: 19.7 mm, FH: 19.6 mm, no PH/FH: 26.7 mm; p = 0.015/p < 0.001). The tumor sizes of patients with a positive PH were almost identical to those of patients with a positive FH (p = 0.999). In women with a positive FH or PH of BC, the increased awareness of BC risk led to the detection of smaller tumors compared to women who have not had this experience. However, comparison of the two risk factors showed that they had a similar impact on the RBE detection rate of BC lesions and that the tumor sizes were nearly identical.
引用
收藏
页码:1387 / 1394
页数:8
相关论文
共 50 条
  • [41] Background parenchymal enhancement in breast MRIs of breast cancer patients: Impact on tumor size estimation
    Baek, Ji Eun
    Kim, Sung Hun
    Lee, Ah Won
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (08) : 1356 - 1362
  • [42] Tumor size and detection in breast cancer: Self-examination and clinical breast examination are at their limit
    Gueth, Uwe
    Huang, Dorothy Jane
    Huber, Marco
    Schoetzau, Andreas
    Wruk, Daniela
    Holzgreve, Wolfgang
    Wight, Edward
    Zanetti-Daellenbach, Rosanna
    CANCER DETECTION AND PREVENTION, 2008, 32 (03): : 224 - 228
  • [43] Long-term effects of first degree family history of breast cancer in young women: Recurrences and bilateral breast cancer
    Jobsen, Jan J.
    van der Palen, Job
    Brinkhuis, Mariel
    Ong, Francisca
    Struikmans, Henk
    ACTA ONCOLOGICA, 2016, 55 (04) : 449 - 454
  • [44] THE CALCULATION OF BREAST-CANCER RISK FOR WOMEN WITH A FIRST DEGREE FAMILY HISTORY OF OVARIAN-CANCER
    CLAUS, EB
    RISCH, N
    THOMPSON, WD
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 28 (02) : 115 - 120
  • [45] IMPACT OF A CHANGING POPULATION STRUCTURE AND CLUSTERING OF CANCER IN PROSTATE CANCER PATIENTS DEPENDING ON A FIRST-DEGREE FAMILY-HISTORY
    Herkommer, Kathleen
    Bittner, Robert
    Meissner, Valentin Henri
    Kron, Martina
    Schiele, Stefan
    Schulwitz, Helga
    Gschwend, Juergen Erich
    JOURNAL OF UROLOGY, 2019, 201 (04): : E598 - E598
  • [46] Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival
    Houvenaeghel, Gilles
    de Nonneville, Alexandre
    Cohen, Monique
    Sabiani, Laura
    Buttarelli, Max
    Charaffe, Emmanuelle
    Jalaguier, Aurelie
    Bannier, Marie
    Tallet, Agnes
    Viret, Frederic
    Goncalves, Anthony
    CANCER MEDICINE, 2024, 13 (03):
  • [47] TUMOR HER2 PROTEIN IN BREAST-CANCER AND FAMILY HISTORY
    LEHRER, S
    LEE, P
    TARTTER, P
    BROWER, S
    LANCET, 1993, 341 (8857): : 1420 - 1421
  • [48] IS BREAST SIZE A PREDICTOR OF BREAST-CANCER RISK OR THE LATERALITY OF THE TUMOR
    SENIE, RT
    SAFTLAS, AF
    BRINTON, LA
    HOOVER, RN
    CANCER CAUSES & CONTROL, 1993, 4 (03) : 203 - 208
  • [49] Evaluation of family history of cancer in first-degree relatives and increased cancer risk: A multinational study
    Modali, Laxmi
    Lehman, Teresa A.
    Modali, Ramakrishna
    Ratnasinghe, Luke D.
    CANCER RESEARCH, 2015, 75
  • [50] First-degree family history of cancer in women with stage I endometrial carcinoma: Prevalence and prognostic impact
    Yousif, Abdelrahman
    Pudar, Julia
    Elshaikh, Muneer
    Khalil-Moawad, Remonda
    Elshaikh, Mohamed
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S139 - S140